Navegação
Perspectivas de mercado Analisador de estoque Calendário de Dividendos Calendário de eventos Classificação de ações Notícias de mercados
Experimente grátis

Abeona Therapeutics

NASDAQ ABEO
$4.40 0.0000 0.0000%
Today share price
EUA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Показатель: 16 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

112.45M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
98.63M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.52
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
25.56M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-12.18 %

Upcoming events Abeona Therapeutics

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Abeona Therapeutics

Stock analysis Abeona Therapeutics

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-2.19 28.88
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
7.58 4.03
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
-2.24 11.32
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
0.31 0.25
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-346.40 10.75

Price change Abeona Therapeutics per year

0.84$ 3.79$
Min Max

Summary analysis Abeona Therapeutics

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Abeona Therapeutics

Revenue and net income Abeona Therapeutics

All parameters

Stock news Abeona Therapeutics

All news
27 novembro 2023 в 18:44

Abeona Therapeutics Shares Jump After FDA Grants Priority Review to Drug for Rare Disorder

27 novembro 2023 в 18:44

Abeona Therapeutics Shares Jump After FDA Grants Priority Review to Drug for Rare Disorder

28 julho 2023 в 14:50

Abeona Therapeutics Submits Briefing Package for Pre-BLA Meeting with FDA

28 julho 2023 в 14:50

Abeona Therapeutics Submits Briefing Package for Pre-BLA Meeting with FDA

3 julho 2023 в 20:05

Abeona Therapeutics Shares Rise 9% After At-the-Market Direct Offering

3 julho 2023 в 20:05

Abeona Therapeutics Shares Rise 9% After At-the-Market Direct Offering

9 junho 2023 в 19:50

Abeona Therapeutics Shares Drop 7% After FDA Feedback for EB-101 BLA

9 junho 2023 в 19:45

Abeona Therapeutics Shares Drop 7% After FDA Feedback for EB-101 BLA

9 junho 2023 в 14:45

Abeona Therapeutics Gets FDA Feedback for EB-101 BLA

9 junho 2023 в 14:45

Abeona Therapeutics Gets FDA Feedback for EB-101 BLA

13 maio 2022 в 15:00

Abeona Therapeutics to Seek Approval for Reverse Stock Split to Regain Nasdaq Compliance

13 maio 2022 в 15:00

Abeona Therapeutics to Seek Approval for Reverse Stock Split to Regain Nasdaq Compliance

About company Abeona Therapeutics

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead programs include EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, an adeno-associated virus-based gene therapy for Sanfilippo syndrome type A; and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B. The company also develops ABO-201 to treat CLN3 disease; ABO-401 for the treatment of cystic fibrosis; and ABO-5OX for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in New York, New York.
Address:
1330 Avenue of the Americas, New York, NY, United States, 10019
Company name: Abeona Therapeutics
Issuer ticker: ABEO
ISIN: US00289Y1073
Country: EUA
Exchange: NASDAQ
Currency: $
IPO date: 1980-09-19
Sector: Healthcare
Industry: Biotechnology
Site: https://www.abeonatherapeutics.com

On which stock exchange are Abeona Therapeutics (ABEO) stocks traded?

Abeona Therapeutics (ABEO) stocks are traded on NASDAQ.

What is the ticker of Abeona Therapeutics stocks (ABEO)?

The stock ticker of Abeona Therapeutics’s stocks or in other words, the code is ABEO. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Abeona Therapeutics (ABEO) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Abeona Therapeutics (ABEO) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Abeona Therapeutics (ABEO) stocks traded?

Abeona Therapeutics (ABEO) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Abeona Therapeutics (ABEO) stocks today?

The current price of Abeona Therapeutics stocks on 21.05.2024 is 4.4 dollars. per share.

What is the dynamics of Abeona Therapeutics (ABEO) stocks from the beginning of the year?

Abeona Therapeutics (ABEO) quotes have increased by -20.43% from the beginning of the year up to 4.4 dollars. per 1 stocks.

How much did Abeona Therapeutics (ABEO) stocks increase in мае 2024?

This month Abeona Therapeutics (ABEO) quotes have increased by 12.53% to 4.4 dollars. per share.

How much are Abeona Therapeutics (ABEO) stocks worth?

Today, on October, 21.05.2024 Abeona Therapeutics’s (ABEO) stocks cost 4.4 dollars..

What is the market capitalization of Abeona Therapeutics (ABEO)?

Capitalization is the market value of Abeona Therapeutics (ABEO) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 21.05.2024, the market capitalization of Abeona Therapeutics (ABEO) is estimated at about 112446294 dollars.